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Abstract 
 
 
Best Practices for Sepsis Patients: A Quality Improvement Project  
 
Kevin Mark Smith Jr 
 
 
Sepsis is a complication caused by the overwhelming and life-threatening response of the 
body to an infection. Sepsis can lead to tissue damage, organ failure, and death (Center for 
Disease Control and Prevention, 2016). Sepsis is the leading cause of death in U.S. hospitals. 
Mortality from sepsis increases 8% for every hour that treatment is delayed. Each year, 258,000 
people die from sepsis in the U.S. As many as 80% of sepsis deaths could be prevented with 
rapid diagnosis and treatment (Sepsis Alliance, 2016). This project seeks to improve the ability 
of the transfer unit to screen patients, improve early recognition and evaluation of best practices, 
and provide a connection with a provider for care consultation. This potential significance of this 
project is to improve patient outcomes including mortality, length of stay, and the assignment of 
patients to the appropriate level of care through early recognition of sepsis and the 
implementation of best practices. The use of a screening process to identify abnormal patient 
variables including elevated serum lactate, decreased blood pressure, elevated respiratory rate, 
and altered mental status can identify an increased likelihood of sepsis.
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Introduction 
This project seeks to improve the process of care delivery for patients transferring to an 
Academic Medical Center with a diagnosis of sepsis. The staff of the transfer unit at the 
Academic Medical Center have recognized delays in transfers of patients with sepsis and 
inconsistencies in sepsis care delivery by sending facilities. The planned project is designed to 
improve the transfer process for these patients by implementing a new sepsis screening tool and 
providing sepsis consultation for outside facilities upon a positive sepsis screen. The objective of 
this project is to support timely evidence based care prior to patient transfer and subsequently 
improve patient outcomes.  
Background 
Sepsis is a complication caused by the overwhelming and life-threatening response of the 
body to an infection. Sepsis can lead to tissue damage, organ failure, and death (Center for 
Disease Control and Prevention, 2016). Sepsis is the leading cause of death in U.S. hospitals. 
Mortality from sepsis increases 8% for every hour that treatment is delayed. Each year, 258,000 
people die from sepsis in the U.S. As many as 80% of sepsis deaths could be prevented with 
rapid diagnosis and treatment (Sepsis Alliance, 2016). According to the CDC, when sepsis is 
quickly recognized and treated, lives are saved. Healthcare providers are the critical link to 
preventing, recognizing, and treating sepsis (U.S. Department of Health and Human Services, 
2016).  
Problem Statement 
The Academic Medical Center of interest does not have an existing process for screening 
and initiating treatment for patients diagnosed with sepsis prior to their transfer from a referring 
facility.  At present, incoming patients are accepted by Throughput RNs in the transfer unit after 
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a series of questions are answered from outlying facility personnel, but there is not a sepsis 
screen being utilized. The Academic Medical Center has transferred a total of 24,766 patients 
from outside healthcare facilities from January 1, 2014 to April 30, 2017. These patient transfers 
include a total of 2,147 (8.6%) patients that were diagnosed with sepsis present on arrival when 
analyzed retrospectively. The early identification and treatment of these patients with sepsis may 
have been enhanced with the implementation of a sepsis screening process. The implementation 
a sepsis screening process in the transfer unit provides opportunities to improve patient care and 
patient outcomes related to sepsis care.  
Purpose of the Project 
 
The purpose of the project is to identify patients with sepsis earlier with the goal 
improving the outcomes of patients received as transfers from outside facilities. Early screening 
of the patients and best practice implementation within the first hour of sepsis presentation is 
critical to improving patient outcomes (Sepsis Alliance, 2016). The use of a sepsis screening 
process by the Throughput RNs at transfer unit of an Academic Medical Center will help achieve 
the purpose. This project seeks to improve the ability of the transfer unit to screen patients, 
improve early recognition and evaluation of best practices, and provide a connection with a 
provider for care consultation. These improvements will allow appropriate and timely care prior 
to patient transfer during the critical first hour of recognition.   
 
Significance of the Proposed Project 
 
This potential significance of this project is to improve patient outcomes including 
mortality, length of stay, and the assignment of patients to the appropriate level of care through 
early recognition of sepsis and the implementation of best practices. The use of a screening 
process to identify abnormal patient variables including elevated serum lactate, decreased blood 
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pressure, elevated respiratory rate, and altered mental status can identify an increased likelihood 
of sepsis. Thus, with this early recognition care providers can intervene earlier and subsequently 
improve patient outcomes. 
Literature Review and Synthesis 
Two separate literature searches were conducted for the completion of this literature 
review. The first search utilized the following databases, CINAHL, MEDLINE, Academic 
Search Complete, and Healthsource: Nursing and Academic Edition. Search keywords included 
sepsis and clinical protocols as subject terms. This search resulted in 493 studies. To be 
including in this review the paper had to address the following: timeliness of the intervention, 
intervention included sepsis protocol or bundle, new onset of sepsis, peer-reviewed, English 
language, and adults. Papers were excluded if: intervention did not include a full sepsis bundle or 
protocol and disease specific related sepsis treatment. This resulted in a total of 42 paper to be 
reviewed. 
 A second review was completed because topics known to the author, such as mortality 
and patient outcomes, were not found in the first review. Using the same search criteria, the 
search keywords of sepsis protocols and mortality were used. This search resulted in 1283 
papers. After applying the same inclusion and exclusion criteria and the removal of duplicates, 
10 additional papers were included.  
Thus, the total number of papers in the review was 52. After a review of these papers, 
three major themes emerged including; the issue of sepsis in hospitals, the impact of sepsis 
screening on recognition of sepsis and the implementation of best practices, and evidence based 
practices for sepsis care. 
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Issue of Sepsis in Hospitals 
The diagnosis and management of patients with sepsis is an important consideration for 
healthcare organizations. Sepsis is a complication caused by the body’s overwhelming and life-
threatening response to infection, which can lead to tissue damage, organ failure, and death 
(CDC, 2016). Sepsis is difficult to predict, diagnose, and treat. Patients who develop sepsis have 
an increased risk of complications and death and face higher healthcare costs and longer 
treatment. From 1999–2014, the CDC found that a total of 2,470,666 decedents (6% of all 
deaths) had sepsis listed among the causes of death (CDC, 2016). Many healthcare organizations 
have acted to improve survival rates and standardize sepsis care. However, sepsis continues to 
burden patient populations and continued efforts to improve healthcare organization’s ability to 
care for these patients is necessary.  
Impact of Sepsis Screening on Recognition of Sepsis and Implementation of Best Practices 
The literature in this review revealed mortality rates of healthcare organization between 
35.1% and 61.1% in sepsis patients prior to implementing a sepsis screening and treatment 
process. Following the implementation of sepsis processes each organization observed decreases 
in mortality. One retrospective cohort study found a decreased mortality from 43.8% to 18.2% 
(Trzeciak et al., 2006). Another study found decrease in mortality rates from 29.7% to 21.1% 
(Jones et al., 2015). A third study found a decreased mortality rate from 39.5% to 20.8% 
(Ngyuyen et al., 2016).   
This review of literature found that many healthcare organizations were able to improve 
the ability to recognize sepsis in early onset with screening tools, thus improve the efficiency of 
best practice intervention delivery.  Twelve studies in the literature review observed statistically 
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significant decreases in the length of time for care providers to recognize sepsis via sepsis 
screening tools (Bruce et al., 2015; Dellinger et al., 2008; Focht et al., 2009; Gaieski et al., 2010; 
Miguel-Yanes, Andueza-Lillo, González-Ramallo, Pastor, & Muñoz, 2006; Hayden et al., 2016; 
Patel et al., 2010; Puskarich et al., 2011; Tromp et al., 2010; Trzeciak et al., 2006; Westfall et al., 
2011; Yealy et al., 2014). Each study that observed an increase in recognition also reported a 
statistically significant decrease in the amount of time to delivery best practices interventions 
including fluid boluses, antibiotic administration, serum lactate level draws, and blood culture 
draws(Bruce et al., 2015; Dellinger et al., 2008; Focht et al., 2009; Gaieski et al., 2010; Miguel-
Yanes et al., 2006; Hayden et al., 2016; Patel et al., 2010; Puskarich et al., 2011; Tromp et al., 
2010; Trzeciak et al., 2006; Westfall et al., 2011; Yealy et al., 2014).  
One study observed the time to antibiotics for patients with severe sepsis and septic shock 
was significantly reduced in the post–BPA cohort from 61.5 minutes to 29.5 minutes. That same 
study observed an improved time to receive antibiotics within 60 minutes from 48.6% to 76.7% 
(Narayanan et al., 2005). A study witnessed improvements in overall time to cultures, first dose 
of antibiotics, and transfers out of the ED to the ICU due to the initiation of the bundle (Patel, 
Roderman, Gehring, Saad, & Bartek, 2010). Another study observed the median time to initial 
antibiotic administration was reduced significantly, by 27 minutes (Bruce et al., 2015). An 
international study found that the mean time elapsed between the identification of the first signs 
of sepsis risk and the detection of sepsis was longer in phase I than in phase II (34 vs 11 hours; P 
< .001) (Westfall et al., 2011). The time to antibiotics for another study revealed the mean time 
to bolus was 31 minutes less in the post implementation group at 51 vs 82 minutes (Geoffrey et 
al., 2016). 
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Therefore, literature suggests that screening for sepsis provides an opportunity for early 
implementation of best practices for sepsis management. These best practices include: fluid 
resuscitation, antibiotics delivery, blood culture draws, and serum lactate draws.  
Evidence Based Practices for Sepsis Care  
Bundles and protocols.  
The standard for the management of sepsis has typically utilized sepsis bundle or 
protocols. A care bundle or protocol is a selected set of care interventions that are designated for 
implementation when a clinical criterion threshold is met.  The adoption of “sepsis bundles” or 
“sepsis protocols” that standardize best practice interventions have shown significant 
improvements in patient care delivery. The implementations of care bundles and protocols have 
been the foundation of sepsis treatment since the initial Surviving Sepsis Campaign-evidenced 
based guidelines introduction in 2004 (Dellinger et al., 2004). The guidelines have continued to 
progress in the subsequent reviews of sepsis care guidelines until the most recent evaluation in 
2016 (Dellinger et al., 2008; Levy MM et al., 2010; Dellinger et al., 2013; Levy MM et al., 2015; 
Rhodes et al., 2015; Rhodes et al., 2017).  
In the 2016 Surviving Sepsis Campaign, the evidence for each individual bundle element 
was graded and evaluated for the level of evidence to support its implementation. The grades and 
recommendation included, lactate level as a weak recommendation with a low quality of 
evidence, the obtaining of blood cultures prior to administration of antibiotics as a best practice 
statement, the administer broad-spectrum antibiotics as a strong recommendation with a 
moderate quality of evidence, the rapidly administration of 30 ml/kg crystalloid for hypotension 
or lactate ≥ 4 mmol/L as a strong recommendation with a low quality of evidence, and the 
application vasopressors if patient is hypotensive during or after fluid resuscitation to maintain 
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MAP ≥ 65 mm Hg as a strong recommendation with a moderate quality of evidence (Rhodes et 
al., 2017). 
  Following the evaluation of evidence, recommendations were made by the Surviving 
Sepsis Committee for the continued use of the following care bundles for the treatment of sepsis 
within the first hours of treatment: measure lactate level and re-measure if initial lactate is > 2 
mmol/L; obtain blood cultures prior to administration of antibiotics; administer broad-spectrum 
antibiotics; rapidly administer 30 ml/kg crystalloid for hypotension or lactate ≥ 4 mmol/L; and 
apply vasopressors if patient is hypotensive during or after fluid resuscitation to maintain 
MAP ≥ 65 mm Hg. Although identified as a weak intervention in the literature, serum lactate was 
included because length of time since patient presented at outside facility to receiving facility can 
vary, thus some patients may have more advanced sepsis making serum lactate level an 
appropriate indicator.  
SIRS criteria.  
The American College of Chest Physicians/Society of Critical Care Medicine established 
the SIRS (systemic inflammatory response syndrome) criteria in a 1991 during a consensus 
conference when tasked with developing clinical parameters for the early identification of sepsis. 
The SIRS criteria identified four clinical variables to be used for the evaluation of sepsis 
including: (1) a body temperature greater than 38°C or less than 36°C; (2) a heart rate greater 
than 90 beats per minute; (3) tachypnea, manifested by a respiratory rate greater than 20 breaths 
per minute, or hyperventilation, as indicated by a PaCO2 of less than 32 mm Hg; and (4) an 
alteration in the white blood cell count, such as a count greater than 12,000/ cu mm, a count less 
than 4,000/cu mm, or the presence of more than 10 percent immature neutrophils (“bands”) 
(Bone et al, 1992). This criterion has been the standard definition for defining sepsis since this 
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consensus conference. However, the AMA (American Medical Association) reported in 2016 
that the current standard of SIRS criteria is unanimously considered to be unhelpful. The AMA 
reported that changes in white blood cell count, temperature, and heart rate reflect inflammation, 
the host response to “danger” in the form of infection or other insults. The SIRS criteria do not 
necessarily indicate a dysregulated, life-threatening response. SIRS criteria are present in many 
hospitalized patients, including those who never develop infection and never incur adverse 
outcomes (American Medical Association. 2016). 
QSOFA and the development of screening tools.  
The use of sepsis screening tools for early identification of sepsis has been critical to the 
improvement of patient care and patient outcomes. With no validated criterion standard 
diagnostic testing to confirm a diagnosis of sepsis, continual efforts have been made to identify 
strategies to predict to sepsis in the early onset. Screening tools for sepsis are imperative to 
properly recognize sepsis in the clinical setting and the delivery of timely care. 
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) 
determined that new criteria for sepsis recognition was useful for the early and accurate detection 
of sepsis.  During the task force it was determined that qSOFA could be a useful clinical tool, 
especially to physicians and other practitioners working outside the ICU (and perhaps even 
outside the hospital, given that qSOFA relies only on clinical examination findings), to promptly 
identify infected patients likely to fare poorly. Also, that this simple bedside score may be 
particularly relevant in resource-poor settings in which laboratory data are not readily available, 
and when the literature about sepsis epidemiology is sparse. The qSOFA score consists of three 
clinical variables including altered mental status, a systolic blood pressure of 100 mm Hg or less, 
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and a respiratory rate of 22/min or greater. The patient is considered as a high likelihood for 
sepsis when two of three clinical variables are present (American Medical Association, 2017).  
Synthesis 
This literature review supports the pursuit of integrating a sepsis screening process using 
nurses within the MARS transfer line by utilizing the American Medical Association consensus 
definition for sepsis and the recommended qSOFA model for sepsis screening (American 
Medical Association, 2016). The recommendation made by the American Medical Association to 
utilize the qSOFA screening for the early identifications of sepsis was determined to be the most 
useful screening tool for the transfer center. The simplicity of the screening and the elimination 
of laboratory tests when compared to SIRS criteria made it more functional for the Throughput 
RNs to complete a quick and easy assessment of transferring patients. With a varying amount of 
information available during the transfer process, this simplicity and lack of need for laboratory 
values is an important consideration.  
 The incorporation of a structured screening tool and a set of pre-determined best practice 
interventions can play an important role in the early recognition of sepsis, timely delivery of best 
practice interventions, and improvements in patient outcomes. Careful considerations regarding 
the structure of the tools and the protocol design can influence patient outcomes. Systematic 
evaluation of the implementation and evaluation of screening protocols is necessary to assess the 
impact screening may have on patient outcomes. This literature review suggests that the priority 
best practice interventions to incorporate in the sepsis screening process are serum lactate level 
draws, blood culture draws, fluid resuscitation, vasopressor administration, and antibiotic 
administration.  
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Theoretical Framework. 
 
The theoretical framework utilized for this project is the Deming Cycle or the 
Plan Do Study Act (PDSA) model. This framework includes four major steps and 
involves a cycle of continual improvement and evaluation. The first  step of this 
framework is the Plan step. The Plan step involves identifying a goal or purpose, 
formulating a theory, defining success metrics, and putting a plan into action. The second Do 
step is when the components of the plan are implemented. The Study step is where outcomes are 
monitored to test the validity of the plan for signs of progress and success or deficits and areas 
for improvement. The Act step closes the cycle by integrating the learning generated by the 
entire process, which can be used to adjust the goal, or change models (The Deming Institute, 
2016).  
Project  
Description and Design 
The project involves the implementation of a screening process and a provider 
consultation to guide care for sepsis patients prior to transferring to an Academic Medical 
Center. The screening process was implemented through the Medical Access Referral System 
(MARS) telephone line, which serves as the main hub for all transfer requests coming into the 
Academic Medical Center from outside facilities. The MARS transfer line is staffed at all times 
by Throughput Nurses. These Throughput Nurses are Registered Nurses responsible for triaging 
and transferring all patients to the Academic Medical Center. The Throughput Nurse will screen 
all adult patients referred to the MARS transfer from all referring facilities.   
The screening utilizes a Quick Sequential [Sepsis-related] Organ Failure Assessment 
(qSOFA) score and a serum lactate level as an indicator of sepsis. The qSOFA score has three 
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clinical variables including altered mental status, a systolic blood pressure of 100 mm Hg or less, 
and a respiratory rate of 22/min or greater (American Medical Association, 2017). The patient is 
considered as a high likelihood for sepsis with two of three clinical variables for the qSOFA 
score and/or an elevation of a serum lactate > 4.0 mmol(36 mg/dl). 
Following the screening process, the Throughput Nurse initiates the care consultation 
when a qSOFA score of two or greater exists and/or an elevation of a serum lactate > 4.0 
mmol(36 mg/dl) exists. If the patient does not score a two or greater and has a serum lactate level 
< 4.0 mmol(36 mg/dl), the consultation will not occur and the standard pathways for patient 
acceptance and admission will be completed. The care consultation process will involve direct 
communication between the referring provider and a designated member of the medical team at 
the Academic Medical Center via the MARS transfer phone line.  Once the consultation is 
completed, the patient will be accepted to an appropriate service and wait for bed placement and 
patient transportation. See Appendix A for Sepsis Screening Process Algorithm 
Pilot Study  
A pilot study will be conducted during the first month of implementation using the PDSA 
theoretical framework for evaluating the project processes. During this period one on one 
interviews, meetings with Throughput RNs and consulting MDs, and a Throughput RN survey 
will be completed to evaluate acceptability, practicality, and limited efficacy. Based on pilot 
study changes will be made to the project (NIH, 2009). 
Fit of Theoretical Framework to Project 
 
The chosen framework works well for this planned project as it provides a solid 
groundwork for a quality improvement project in a healthcare organization. It analyzes each 
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stage of a change project as it would naturally occur and allows for evaluation of outcomes and 
reentrance into the cycle to perfect the system change. (See Appendix B)  
Feasibility Analysis 
 
The planned project intervention is driven by current clinical guidelines repurposed for 
patient transfers via the MARS transfer line. The current screening methods and consultation 
process is an approved organizational process. (See Appendix A) The functional requirements 
involve a software system adaptation that will integrate the sepsis screening alert into MARS 
transfer process. There are no confidentiality, privacy, or security issues with the change project. 
The proposed change is feasible within known technical constraints and current staff skills. The 
change requires no additional demands on human resources. The change will affect the amount 
of time for each MARS transfer call by an estimated 2 to 10 minutes.  
Project resources.  
The total costs of the project will be covered by organizational contributions. The hourly 
wage contribution of the organization constitutes 98% of the of the total project costs. The hourly 
wages are required for educational sessions and additional time spent during transfer calls. The 
hourly wages reflect current full time employees in their current roles within the organization. 
No additional personnel will be required outside of their current role for the implementation of 
the project. The participation of one House Supervisor will be voluntary as they are a key 
contributor to the planned project. The House Supervisor’s role is to work directly with the 
Throughput Nurses to oversee patient transfers and manage bed placement. See the attached 
capstone budget plan and justification (See Appendix D). 
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Organizational and project needs assessment.  
The planned project utilizes current MARS line throughput nurses and on call internal 
physicians working within their current roles. No additional staff will be required for the 
implementation or continuation of the project. The screening process will require additional time 
per MARS transfer call but it require no addition organizational workflow changes to 
accommodate the additional time. The training will be completed by the MARS supervisor and 
the principle project champion and will require no additional training personnel. The Throughput 
nurse training sessions will be completed during their normal working hours and will require no 
additional time for completion. Training for the sepsis expert consultation will occur during work 
hours and will require no additional resources. (See Appendix C) The planned project reinforces 
and expands the existing sepsis screening tools and sepsis protocols for care. No additional needs 
are identified to implement these aspects of the project.   
A strengths weaknesses opportunities and threats (SWOT) analysis was performed for 
this project and indicated the strengths of this project to be interdisciplinary support for change, 
support by current MARS line employees, limited financial investment necessary for change, 
sepsis experts and clinical expertise within the organization, and strong leadership support for 
change. The weaknesses for the project were identified as inconsistent organizational use of the 
current sepsis BPA alert and sepsis protocol orders, and the potential resistance of internal care 
providers. The opportunities that were identified included the organization’s positioning as the 
leader of a growing health system in its state, the organization serving as the main destination for 
tertiary care transfers in the state, and the organization’s strong financial positioning. The threats 
to the project included external physician’s resistance to change, and the inconsistencies of 
external physician’s preferences on the delivery of care.  
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Congruence to the strategic plan of the organization.  
WVU Medicine’s mission is to improve the health of West Virginians and all we serve 
through excellence in patient care, research, and education. (WVU Medicine, 2017) The planned 
project’s goals of improving the transfer process for sepsis patients and improving patient 
outcomes aligns well with WVU Medicine’s mission statement. This project has the potential to 
reach a large population of West Virginians through collaborative patient care strategies, 
education of healthcare providers, and the research of evidence based practice application within 
the organization’s health system.  
The planned project aligns well with the vision of the organization. The project will seek 
to expand the delivery of expert evidence based care throughout the organization’s health 
system. It seeks to unify a culture of care delivery to its highest level and transform the delivery 
of care so that its population can receive the right care in the right place at the right time. WVU 
Medicine’s Vision is to: 
Transform lives and eliminate health disparities through a nationally recognized patient-
centered system of care that includes: An expanded regional healthcare delivery system, 
consistent, integrated patient care recognized for delivering the right care in the right 
place at the right time at all sites, development of new approaches to improve healthcare, 
including team-based models of care, expanding WVU clinical and translational research, 
educational programs throughout the network recognized for training uniquely qualified 
healthcare team members and leaders, and a culture of performance and excellence 
throughout the network (WVU Medicine, 2017). 
Evidence of key site support.  
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The principle stakeholders for the planned project are the MARS transfer line leadership 
team. This MARS leadership team, including the Director and Manager, has offered their support 
for the implementation of the project. Other key stakeholders that have offered support for the 
project include the organization’s Chief Operating Officer, members of the sepsis committee, the 
Director of the Center for Quality Outcomes, and the Chief Quality Officer.  
Project Timeline  
The planned phases of the project will begin with the Institutional Review Board process 
to be completed by December 15, 2017. The education sessions for both the Throughput RNs 
and sepsis consult experts will be completed by January 15, 2018. The planned project’s 
intervention implementation will take place on February 1, 2018 and will be monitored for three 
months through April 30, 2018.  An audit and chart review of retrospective data for transferring 
will be completed by March 1, 2018 to determine effectiveness and sustainability. The final 
presentation of the project, including an overview and a project analysis will be conducted by 
December 1, 2018. (See Appendix E) 
Measurable Project Aims and Objectives 
The proposed project has two main aims. These aims are, Aim 1: to evaluate the 
usefulness of a new sepsis screening process and Aim 2: to evaluate the impact of the new sepsis 
screening process on patient outcomes. See Table 1. 
Aim 1 has three main objectives. Objective 1: the screening accurately identifies those 
patients with sepsis present on arrival; AEB: A: the total number of positive screens with a 
diagnosis of sepsis present on arrival(true positives), B: the total number of negative screens with 
a diagnosis of sepsis present on arrival(false negatives), C: the total number of positive screens 
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without a diagnosis of sepsis present on arrival(false positives), and D: the total number of 
negative screens without a diagnosis of sepsis(true negatives).  
For objective 1, sensitivity and specificity will be calculated using the true positive, false 
negative, true negative, and false positive results. Sensitivity is calculated to measure the 
proportion of actual positives that are correctly identified as such (true positives/true positives + 
false negatives). Specificity is calculated to measure the proportion of actual negatives that are 
correctly identified as such (true negatives/true negatives + false positives). 
Objective 2: Increase the number of patients receiving Best Practices for sepsis 
management, AEB: An increase the number of Best Practices implemented from initial screening 
to arrival at WVU Medicine- Ruby Memorial. Objective 3: Implementation of screening will be 
timely and efficient, AEB: A: the number of minutes for throughput nurse to screen for sepsis 
and evaluate Best Practices and B: the number of minutes for screening to provider/transfer 
connection. 
Aim 2 has one main objective. Objective 1: implementation of sepsis screening process 
will improve patient outcomes, AEB: A: decreased length of stay in the post-implementation 
period compared to the pre-implementation period, B: decreased mortality rate in the post-
implementation period compared to the pre-implementation period, and C: decreased escalation 
of care prior to transfer or within the first 24 hours of admission to WVU Medicine Ruby 
Memorial. 
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Table 1:  Measurable Project Aims and Objectives: Evaluation Plan 
Aim Objective/Criteria, AEB Target 
Population 
What Data to Collect Collection 
Methods 
Data Analysis 
Aim1: 
Evaluate 
the 
usefulness 
of a new 
sepsis 
screening 
process 
1. Screening accurately identifies 
those patients with sepsis present 
on arrival, AEB: 
 
A. Total number of positive 
screens with a diagnosis 
of sepsis present on 
arrival (True positives) 
B. Total number of positive 
screens without a 
diagnosis of sepsis 
present on arrival (False 
positives) 
C. Total number of negative 
screens with a diagnosis 
of sepsis present on 
arrival (False negatives) 
D. Total number of negative 
screens without a 
diagnosis of sepsis (true 
negatives) 
 
 
 
 
 
Nurses 
Consultants 
Outside 
facilities 
Patients 
Medical 
Records 
Objective 1. qSOFA 
scores and/or Serum 
Lactate levels 
compared to sepsis 
diagnosis POA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chart 
Review 
 
Call- Miner 
transcripts 
 
Objective 1. Quantitative 
analysis using descriptive 
statistics, frequencies, and 
percentage calculations 
 
Sensitivity and specificity 
calculations using standard 
formulas. 
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2. Increase the number of patients 
receiving Best Practices for 
sepsis management, AEB: 
A. Increase the number of 
Best Practices 
recommended during the 
consultation, measured at 
Time 4. 
B. Increase the number of 
best practice implemented 
prior to arrival at WVU 
Medicine- Ruby 
Memorial, measured at 
Time 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Objective 2. Best 
practices (antibiotics 
administered, serum 
lactate drawn, fluid 
resuscitation 
administered, and 
blood cultures drawn) 
at baseline, 
recommended during 
the consultation 
(Time 4), and 
actually implemented 
after the consultation 
(Time 5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Objective 2. Quantitative 
analysis using descriptive 
statistics, frequencies, and 
percentage calculations 
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3. Implementation of screening 
will be timely and efficient, AEB: 
A. Number of minutes for 
throughput nurse to 
screen for sepsis and 
evaluate Best Practices 
(Time 1-Time 2) 
B. Number of minutes for 
screening to 
provider/transfer 
connection (Time 2- Time 
3) 
 
Objective 3. Data 
collected at project 
time points: Time1, 
Time 2, and Time 3. 
Objective 3. Quantitative 
analysis using descriptive 
statistics including frequency 
and central tendency to 
describe interval data. 
 
 
Aim 2: 
Evaluate 
the impact 
of the new 
sepsis 
screening 
process on 
patient 
outcomes 
Objective 1. Implementation of 
sepsis screening process will 
improve patient outcomes, AEB:  
A. Decreased length of stay 
in the post-
implementation period 
compared to the pre-
implementation period 
B. Decreased mortality rate 
in the post-
implementation period 
compared to the pre-
implementation period 
C. Decreased escalation of 
care prior to transfer or 
within the first 24 hours 
of admission to WVU 
Medicine Ruby 
Memorial. 
Patients 
pre/post-
process 
implementa
tion 
Objective 1. Length 
of stay, mortality 
rate, escalation of 
care. 
Chart 
review 
Objective 1A. Quantitative 
analysis using descriptive 
statistics including frequency 
and central tendency 
comparing pre- 
implementation interval data 
(length of stay) to post-
implementation interval data 
(length of stay). t-test to 
determine statistical difference 
between the pre/ post data on 
continuous variable of LOS. 
Chi Square Goodness of fit test 
to compare differences 
between pre/post data on 
categorical variables.  
 
Objective 1B. Quantitative 
analysis using descriptive 
statistics including frequency 
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and central tendency 
comparing pre- 
implementation nominal data 
(mortality) to post-
implementation nominal data 
(mortality). t-test to determine 
statistical difference between 
the pre/ post data. 
 
Objective 1C. Quantitative 
analysis using descriptive 
statistics including frequency 
and central tendency 
comparing pre- 
implementation nominal data 
(escalation of care) to post-
implementation nominal data 
(escalation of care). Chi 
Square Goodness of fit test to 
compare differences between 
pre/post data on categorical 
variables. 
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Results 
1270 patients were screened during the study period. The sample ages ranged from 18 to 
99, including 85(6.69%) age 18-29, 82(6.46%) age 30-39, 130(10.24%) age 40-49, 233(18.35%) 
age 50-59, 295(23.23%) age 60-69, 289(22.76%) age 70-79, 139(10.94%) age 80-89, and 
17(1.34%) age 90-99. The majority of the screened patients were white (98.19%), 1.57% were 
black, less than 1% were Asian, less than 1% were Hispanic, and less than 1% reported than 
ethnicity as other. 191(15.04%) were commercially insured, 306(24.09%) were Medicaid, 
757(59.61%) were Medicare, 2(0.16%) were insured through workers compensation, and 
14(1.10%) were self-pay or uninsured. Screened patients were from 67 different facilities in 49 
counties located throughout West Virginia, Kentucky, Virginia, Pennsylvania, and Ohio.  Refer 
to Table 1 for a more detailed description of the demographics. See figure 1. 
Of the 1270 patients screened, 225 patients were confirmed with sepsis upon arrival to 
the academic medical center. The majority of the screened patients were white (97.78%%), 
1.78%% were black, less than 1% were Hispanic, are no patients reported as an ethnicity of 
Asian or Other. Gender distribution of the patients was similar, 55.56% of the sample were male 
and 44.44% were female. The patients with the diagnosis of sepsis present on arrival ages ranged 
from 18 to 98, including 19(8.44%) age 18-29, 15(6.67%) age 30-39, 24(10.67%) age 40-49, 
39(17.33%) age 50-59, 64(28.44%) age 60-69, 45(20.00%) age 70-79, 17(7.56%) age 80-89, and 
2(0.89%) age 90-99. 73.33% of the patients were > the age of 50 with the largest number of 
patients between the ages of 60-69. 28(12.44%) were commercially insured, 72(32.00%) were 
Medicaid, 124(55.11%) were Medicare, 0 were insured through workers compensation, and 
1(0.44%) were self-pay or uninsured. See Table 2.  
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Figure 1 
 
Table 2 
 
Group Characteristic Category Total Screened(1270) Total Sepsis POA(225) 
 
 
Ethnicity 
White 1246(98.11%) 220(97.78%) 
Black 20(1.57%) 4(1.78%) 
Asian 2(0.16%) 0(0.00%) 
Hispanic 1(0.08%) 1(0.44% 
Other 1(0.08%) 0(0.00% 
Gender Male 668(52.60%) 125(55.56%) 
Female 602(47.40%) 100(44.44%) 
 
 
 
Age 
18-29 85(6.69%) 19(8.44%) 
30-39 82(6.46%) 15(6.67%) 
40-49 130(10.24%) 24(10.67%) 
50-59 233(18.35%) 39(17.33%) 
60-69 295(23.23%) 64(28.44%) 
70-79 289(22.76%) 45(20.00%) 
80-89 139(10.94%) 17(7.56%) 
90-99 17(1.34%) 2(0.89%) 
 
 
 
Commercially 
insured 191(15.04%) 28(12.44%) 
Medicaid 306(24.09%) 72(32.00%) 
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Payor Source Medicare 757(59.61%) 124(55.11%) 
Workers 
compensation 2(0.16%) 0(0.00%) 
Self-pay or 
uninsured 14(1.10%) 1(0.44%) 
 
Aim1: Evaluate the Usefulness of a New Sepsis Screening Process  
Objective 1.  
Screening accurately identifies those patients with sepsis present on arrival, AEB: 1a. The 
total number of positive screens with a diagnosis of sepsis present on arrival. 1b. The total 
number of negative screens with a diagnosis of sepsis present on arrival. 1c. The total number of 
positive screens without a diagnosis of sepsis present on arrival. 1d. The total number of negative 
screens without a diagnosis of sepsis. 
Objectives 1 A/B. 
Out of 1270 patients screened for likelihood of sepsis, 159 screened high likelihood for 
having sepsis, and 1111 screened likelihood of being negative for sepsis. Of the 159 screened 
high likelihood, 92 had a positive diagnosis of sepsis on arrival, and 67 did not have a diagnosis 
of sepsis on arrival. Thus screening accurately identified 57.9% (screened positive who were 
actually positive/total number screened positive) of the “true positives” for a diagnosis of sepsis 
on arrival; however, 42.1% did not have sepsis, but screened high likelihood of having sepsis, or 
“false positives”.   
Objectives 1 C/D. 
Of the 1111 screened likelihood of being negative for sepsis, there were actually 133 
patients with a positive diagnosis of sepsis (“false negative”) on arrival, and 978 did not have a 
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diagnosis of sepsis on arrival (“true negatives”).  Thus, 88% were appropriately screened as 
negative likelihood for sepsis and did not have a diagnosis of sepsis on arrival.  
From objective 1 sensitivity and specificity were calculated. Sensitivity (also called the 
true positive rate) measures the proportion of actual positives that are correctly identified as such 
(e.g., the percentage of patients with sepsis who are correctly identified as having sepsis). 
Overall sensitivity was 40.89% (true positives/true positives + false negatives). Specificity (also 
called the true negative rate) measures the proportion of actual negatives that are correctly 
identified as such (e.g., the percentage of patients without sepsis who are correctly identified as 
not having sepsis). Overall specificity was 93.59% (true negatives/true negatives + false 
positives). Refer to Table 3 for a more detailed description of screening results. 
Table 3 
Total # Screened 1270 
    Of those screened, #of positive screens     159 
    Of those screened, #of negative screens     1111 
Total # with diagnosis of sepsis POA 225 
    Of those screened positive, # with sepsis POA     92 
    Of those screened negative, # with sepsis POA     133 
Total # without a diagnosis of sepsis POA 1045 
    Of those screened positive, # without sepsis POA     67 
    Of those screened negative, # without sepsis POA     978 
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159 (11.44%) of the 225 confirmed patient with sepsis present on arrival had positive 
screens. Out of that 159, 18 (11%) had a qSOFA score of 2 or greater and a serum lactate level of 
4.0mmol/l (36 mg/dl) or greater, 38 (24%) patients had a serum lactate level of 4.0mmol/l (36 
mg/dl) or greater alone, and 103 (65%) had a qSOFA score of 2 or greater alone.  
In determining whether a screen is positive or not, a patient could have a positive qSOFA 
score and/or an elevated Serum Lactate level. 159(11.44%) of the 225 confirmed patient with 
sepsis present on arrival had positive screens; 18 had a qSOFA score of 2 or greater and a serum 
lactate level of 4.0mmol/l(36 mg/dl) or greater, 38 patients had a serum lactate level of 
4.0mmol/l(36 mg/dl) or greater alone, and 103 had a qSOFA score of 2 or greater alone. Refer to 
Table 4 for a more detailed description of the screening triggers.  
Table 4 
Total number of positive screens 159 
qSOFA score > 2 and Serum lactate >4.0mmol/l(36 mg/dl) 18 
Serum lactate >4.0mmol/l(36 mg/dl) alone 38 
qSOFA score > 2 alone 103 
 
Objective 2. 
Increase the number of patients receiving Best Practices for sepsis management, AEB:  
2a. An increase in the number of Best Practices implemented from initial screening to arrival at 
the academic medical center. 
Number of best practices implemented prior to consultation.  
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Of the 159 patient positive screens in the pre-consultation period (Time 2), 80(50.31%) 
received fluid resuscitation, 113 (71.7%) received antibiotics, 107 (67.3%) had blood cultures 
drawn, and 128 (80.50%) had a serum lactate level drawn. Of the 92 true positives for sepsis 
(determined by confirmed diagnosis of sepsis POA) in the pre-consultation period, 54 (58.70%) 
were receiving fluid resuscitation, 82 (89.13%) were receiving antibiotics, 68 (73.91%) had 
blood cultures drawn, and 77 (83.70%) had serum lactate drawn. Refer to Table 5. 
Number of best practices recommended. 
Of the 92 positive screens with confirmed sepsis POA, a total of 24 best practice 
recommendations were made during the consultation period, which was measured at Time 3. 
This data included: 9 (9.78%) for fluid resuscitation or pressor administration, 14 (15.22%) for 
antibiotic administration, and 1 (1.09%) for blood culture draws. No recommendations were 
made during the consultation period for serum lactate level draws. Refer to Table 5. 
Number of best practices implemented. 
16 of the 24 total recommendations were confirmed as completed prior to arrival via 
chart review including, 8(8.7%) of the fluid resuscitation or pressor administration 
recommendations, 7(7.61%) of the antibiotic recommendations, and the 1(1.09%) blood culture 
draw recommendation. Refer to Table 5. 
Table 5 
Best Practices Implemented Prior to Consultation Positive Screens (159) 
Fluid resuscitation/ pressor 80 (50.31%) 
Antibiotics 113 (71.07%) 
Blood cultures 107 (67.30%) 
Serum Lactate 128 (80.50%) 
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Objective 3. 
Implementation of screening will be timely and efficient, AEB: 3a. The number of 
minutes for throughput nurse to screen for sepsis and evaluate Best Practices (Time 1 to Time2). 
3b. The number of minutes for the completion of the screening to consultation connection (Time 
2 to Time 3). 
Of the 159 patients screening positive, times were capture for 125 patients. The mean 
number of minutes for throughput nurse to screen for sepsis and evaluate Best Practices was 
00:02:26 (median = 2:00; mode = 2:00; range = 1:00 – 11:00). The mean number of minutes 
from screening to provider/transfer connection was 10:13 minutes (median = 6:00; mode = 4:00; 
range: 1:00 – 2:11:00).  
Aim 2: Evaluate the Impact of the New Sepsis Screening Process on Patient Outcomes 
Best Practices Implemented Prior to Consultation True Positives (92) 
Fluid resuscitation/ pressor 54 (58.70%) 
Antibiotics 82 (89.13%) 
Blood cultures 68 (73.91%) 
Serum Lactate 77 (83.70%) 
Number of Best Practices Recommended True Positives (92) 
Fluid resuscitation/ pressor 9 (9.78%) 
Antibiotics 14 (15.22%) 
Blood cultures 1 (1.09%) 
Serum lactate 0 (0.00%) 
Total 24 
Number of Best Practices Implemented True Positives (92) 
Fluid resuscitation/ pressor 8 (8.70%) 
Antibiotics 7 (7.61%) 
Blood cultures 1 (1.09%) 
Serum lactate 0 (0.00%) 
Unable to determine via chart review 8 (8.70%) 
Total confirmed via chart review 16 
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Implementation of sepsis screening process will improve patient outcomes, AEB: 2a. A 
decreased length of stay in the post-implementation period compared to the pre-implementation 
period. 2b. A decreased mortality rate in the post-implementation period compared to the pre-
implementation period. 2c. A decrease in escalation of care prior to transfer or within the first 24 
hours of admission to the academic medical center. 
Objective 1A: LOS.  
Of the 244 patients transferred with a diagnosis of sepsis present or arrival between 
November 1st, 2017 and January 31st. 2018, length of stay was 12.7 days. Of the 225 patients 
transferred with a diagnosis of sepsis present on arrival between February 1st, 2018 and April 
30th, 2018, length of stay was 14.87 days. A 2.17 day increase in length of stay was witnessed 
between the pre-implementation period and the post-implementation period. However, statistical 
analysis revealed that this difference was not significant (p = .098). See Appendix F describing 
statistical analysis. 
Objective 1B: Mortality. 
Of the 244 patients transferred with a diagnosis of sepsis present or arrival between 
November 1st, 2017 and January 31st. 2018, mortality occurred in 74(30.33%) cases. Of the 225 
patients transferred with a diagnosis of sepsis present on arrival between February 1st, 2018 and 
April 30th, 2018, mortality occurred in 50(22.22%) cases. A decreased mortality rate of 8.11 
percentage points was observed between the pre-implementation period and the post-
implementation period. Statistical analysis revealed that there is a significant difference in 
mortality, x2 (1, n = 225) = 6.48, p = .01. See Appendix F describing statistical analysis. 
Objective 1C: EOC. 
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Of the 244 patients transferred with a diagnosis of sepsis present or arrival between 
November 1st, 2017 and January 31st. 2018, escalation of care occurred in 46(18.85%) cases. Of 
the 225 patients transferred with a diagnosis of sepsis present on arrival between February 1st, 
2018 and April 30th, 2018, escalation of care occurred in 34(15.11%) cases. A decreased 
escalation of care of 3.74 percentage points was observed between the pre-implementation 
period and the post-implementation period. There were no significant differences between the 
pre-intervention and the post-intervention groups on EOC. See Appendix F describing statistical 
analysis. 
Discussion and Recommendations 
Theoretical Framework 
The theoretical framework utilized for this project is the Deming Cycle or the Plan 
Do Study Act (PDSA) model. This framework’s four major steps were operationalized 
throughout the implementation of this project. The first step of this framework is the 
Plan step. The Plan step involves identifying a goal or purpose, formulating a theory, defining 
success metrics, and putting a plan into action models (The Deming Institute, 2016). During the 
plan phase, a literature review was completed. The key organizational stakeholders were 
identified and recruited for implementation support. The project AIMs and objectives were 
developed. A sepsis steering committee was formalized and organized with a focus on sepsis 
treatment for patient transfers. The establishment of baseline organizational measures was 
completed and the formation of key measures for the project were outlined to measure the 
effectiveness of the process.  
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The second Do step is when the components of the plan are implemented (The Deming 
Institute, 2016). In this step, a documentation process was built within the electronic health 
record system at the site of the implementation. Education sessions were completed with site 
providers and Throughput RNs. Meetings were conducted with the key project stakeholders. The 
sepsis screening process was then implemented during this step with a continued evaluation of 
the process steps.  
The Third Study step is where outcomes are monitored to test the validity of the plan for 
signs of progress and success or deficits and areas for improvement (The Deming Institute, 
2016). This step was utilized continually throughout the duration of the study. After 1 month of 
studying the intervention, the study step was utilized via a staff survey and employee interviews. 
The three lessons learned during the first month of study were a variance in the Serum Lactate 
measurement, the inability to gather a GCS consistently at some outside facilities, and a varying 
definition of fluid resuscitation at sending facilities. Adjustments were made based on these 
finding and addressed in the next act step.  
The Act step closes the cycle by integrating the learning generated by the entire process, 
which can be used to adjust the goal, or change models. It was realized during the study phase 
that adjustments were needed to the processes. During this phase, adjustments to the screening 
process were made including Serum Lactate measurements, fluid resuscitation definitions, and 
altered mental status measurements. Serum Lactate for some sending facilities was found to be 
measured in mg/dL. Thus, the screening threshold for Serum Lactate was adjusted to 4mmol/L or 
36 mg/dL to accommodate both measurements. The inability to consistently collect a GSC from 
sending facilities was also realized. Thus, a transition of the screening to altered mental status 
from GSC was made to improve the efficiency and ability of the throughput RNs to perform the 
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screening. A varying definition of fluid resuscitation at sending facilities was also recognized. 
An adjustment to a more detailed questioning on fluid resuscitation was made to accurately 
define the exact amount of fluid received at the sending facility prior to the transfer call rather 
than the previous binary response of yes or no. Following these adjustments, the processes were 
then quickly cycled back into the theoretical framework for continued study. The ability for 
quick rapid cycle improvements made the PDSA model idealistic for the implementation this 
project.  
Clinical Significance of Study Findings 
 The implementation of the sepsis screening process had a clinically significant impact on 
this patient population. EOC: The 3.74 percentage points decrease in escalation of care decreased 
the burden of resources needed to move patients between care units. An increase in the 
recognition of patient’s acuity level and a subsequent prioritization in bed placement allowed for 
patients to be assigned to beds earlier. The improved assignment of patients to the appropriate 
level of care also allowed the appropriate care interventions to be started immediately upon 
arrival to the hospital with the resources needed in place to monitor and perform care.  
Mortality: The decrease in mortality of 8.11 percentage points clinical significance was 
related to the placement of these patients in the correct level of care, an improvements in the 
awareness of these septic patients by the Throughput RNs and Bed Coordinators that prioritized 
these patients, the provider consultations that occurred, and the increase in interventions 
delivered at outside facilities based on the recommendations of the providers during consultation.  
Length of Stay: The 2.17 day increase in length of stay observed could be directly related 
to the decrease in mortality observed in the pre/post groups. Mortality and early death in patients 
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transferring with sepsis are typically linked to shorter lengths of stay. Thus, the decrease in 
mortality could play a large role in these added days. The screening was also found to more 
accurately identify severe sepsis cases than the less acute sepsis cases A sub analysis of the 
transferring patient’s severity of illness was completed to describe the sensitivity of the screening 
process for severe sepsis. The sub analysis revealed that the sepsis screening screened 58.26% of 
the severe sepsis patients accurately and only 22.78% of the lower severity sepsis patients 
accurately. The screenings ability to identify higher acuity cases, may have skewed the LOS 
findings because less of the lower acuity level cases were recognized where LOS could be 
improved significantly. A longer timeframe for data analysis could reveal more stable lengths of 
stay or possibly shorter lengths of stay with the continued implementation of this process.  
Recommendations for the Site 
Throughout the implementation of this project, recommendations for the site were 
evaluated for the continuation of this project and the potential implementation of future projects. 
The Deming Cycle or the Plan Do Study Act (PDSA) model served as a successful 
theoretical framework for the process implementation at the site. It would be 
recommended as a beneficial theoretic framework for any future comparable project 
implementation at this site. 
Continuation of the project with an expansion on the screening criteria would be 
recommended for the site. A recommendation for the site practice moving forward is to include 
the patient’s lowest blood pressure at the sending facility instead of the most current blood 
pressure. This suggestion is based on provider feedback and call analysis the recognized missed 
sepsis diagnosis based on blood pressure. It was recognized that patients were being screened as 
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normotensive related to fluid boluses at the time of the transfer call but they were truly 
hypotensive prior to the fluid boluses and upon arrival the academic medical center.  
For future project implementations, an improvement in the call management technology 
would be recommended for the site. The current call management technology had limited call 
data accessibility, it lacked interfacing capabilities with the electronic health record, it was 
limited in the storage space needed for call retrieval, and it failed to capture periods of call data.  
A lack of adherence to standing policy at the transfer center was also recognized during 
the study period. During the study period adherence to the collection of standard vital signs and 
mental status were not completed on 25 patients in the first month, 15 patients in the second 
month, and 12 patients in the third month. Monthly call review and follow-up correspondence of 
call analysis were conducted throughout the study to improve adherence. A more vigorous 
schedule of call analysis, data collection, and feedback mechanism for all calls in the transfer 
center would also be recommended for this site. The performance measurement frequency 
recommended for the site includes an initial monthly evaluation during the change phase, 
quarterly evaluations after the aim or goal is achieved, and annually following the 
accomplishment of the goal and the establishment of stable performance (U.S. Department of 
Health and Human Services Administration, 2011). 
Recommendations for Other Settings 
The project implementation would be feasible for any patient transfer center due to the 
simplicity of the screening process.  The project is scalable to any transfer center and the 
fundamental framework could be executed at any call center without the adoption of any 
technology or large expenditures. However, the project would be most effective for a similar size 
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academic medical center with the available resources and expertise needed to answer the transfer 
line call and provide consultation 24 hours a day and 7 days a week.  
The data evaluation process utilized for this project would require specific resources that 
may not be available in all other settings. A call management system or a comparable call 
recording process would be an important consideration for evaluation of the process. The 
electronic health record system would be a key consideration for another setting for data 
capturing during the evaluation of screening scores, best practices, time stamps, and patient 
outcomes evaluation. Also, a consistent technological platform and method for confirming the 
admittance diagnosis of patients is essential for the evaluation of the screening tool.  
Attainment of DNP Essentials 
Essential I. Scientific Underpinnings for Practice. 
This project demonstrates substantial content for this essential as it sought to evaluate practice 
approaches from both nursing and medical evidenced based practice with underlying scientific 
underpinnings to improve care delivery for this critically ill patient population. The project was 
completed within a theoretic framework that guided its focus to integrate nursing and 
organization science to inform the practice change.  
Essential II. Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking.  
This essential was met throughout the planning and implementation of this project. High level 
stakeholders from West Virginia’s largest tertiary academic healthcare center were involved. The 
project systematically involved the development of policies and protocols, organizational 
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education to support policy and protocol implementation, and leading the organizational change 
from beginning to end. 
Essential III. Clinical Scholarship and Analytical Methods for Evidence-Based Practice.  
During the implementation of this project, a thorough review of the literature and an analysis of 
evidenced based practices was completed to inform the practice change. The examination of the 
evidence informed the development of the project, the establishment of measures, and 
mechanisms for evaluating the project outcomes.  
Essential IV. Information Systems/Technology and Patient Care Technology for the 
Improvement and Transformation of Health Care 
This essential was used for all aspects of this project. The project required the use of three major 
IT systems for implementation and evaluation. During the implementation of this project two 
database builds were required for evaluation and a process was built within the electronic health 
record to complete the project’s implementation. This use of IT was imperative to design this 
project and the ability of the project to improve the delivery of care for these patients.  
Essential V. Health Care Policy for Advocacy in Health Care. 
This project required a thorough evaluation of the organizations existing policies and 
collaboration with decision makers in the organization for a new policy implementation. A new 
policy was then designed and implemented that directed that practice change. From a broader 
standpoint, Federal regulations as defined by CMS recently added sepsis patient care to publicly 
reportable information with an ultimate link to hospital reimbursement.  
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Essential VI. Interprofessional Collaboration for Improving Patient and Population Health 
Outcomes. 
This project required many disciplines to become stakeholders and participants in the process 
change. Physicians, Pharmacists, Researchers, Nurses, Administrators, Advanced Practice 
Professionals, and Executive leadership were pivotal to the successful completion of the 
development and implementation of the project. This essential was exemplified through the 
leadership of this interdisciplinary team to successfully implement this change project.  
Essential VII. Clinical Prevention and Population Health for Improving the Nation’s 
Health. 
This project met this essential by focusing on the sepsis population and improving the health of 
these patients by influencing and incorporating a new care delivery model. Beyond the 
immediate academic health center, it serves a tertiary care center population through a significant 
region that may have improvements in health secondary to the implementation of this project. 
The new care delivery model served a region including 67 different facilities in 49 counties 
located throughout West Virginia, Kentucky, Virginia, Pennsylvania, and Ohio. 
Essential VIII. Advanced Nursing Practice. 
This essential was met through the assessment of a complex health situation and disease state 
and the design and implementation of an intervention to meet the needs of these patients. This 
required leading a healthcare team to change their practice, analysis of the complex results for 
clinical significance, and continual quality improvement of the practice change.  
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Appendix A 
Sepsis Screening Process Algorithm  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. An outside facility provider contacts the WVU Medicine MARS 
transfer line requesting a patient transfer. 
 
 
2. The WVU Medicine sepsis screening process is initiated through a 
series of questions asked by the Throughput RN including the 4 
following criteria: 
QSOFA 
A. Altered Mental Status: GCS < 15 = 1 point 
➢ “Does the patient have an altered mental 
status?” 
B. Respiratory Rate > 22 breaths per minute = 1 point 
➢ “What is the patient’s current respiratory rate?” 
C. Systolic Blood Pressure < 100 mm Hg = 1 point 
➢ “What is the patient’s current blood pressure?” 
 
Serum Lactate  
A. Serum Lactate Level > 4 mmol/L(36mg/dL) 
➢ “What is the patient’s serum lactate level?” 
 
 
 
3. The Throughput RN evaluates the total WVU Medicine QSOFA 
score and a serum lactate level to determine a need for the sepsis 
consultation. Each QSOFA criterion has a value of 1 point 
4. The Throughput RN evaluates if the 4 following best practices 
have been implemented. 
A. Fluid resuscitation at 30ml/kg/ Vasopressor 
administration 
➢ “Has the patient received fluid resuscitation 
or Vasopressor administration?” 
➢ “If yes, what specific fluids or vasopressor?” 
B. Antibiotic administration 
➢ “Has the patient received antibiotics?” 
➢ “If yes, what antibiotics have been 
administered?” 
C. Blood culture draws 
➢ “Have blood cultures been drawn?” 
D. Serum Lactate level draw (if not already known) 
➢ “Has a lactate level been drawn?” 
 
 
WVU Medicine QSOFA score < 2 points and Serum 
Lactate Level < 4 mmol/L(36mg/dL): Sepsis screening 
process stop 
 
 
WVU Medicine QSOFA score > 2 points and/or Serum Lactate 
Level > 4 mmol/L(36mg/dL) l: Continue to step 4 
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8. The WVU Medicine attending provider guides care to ensure that the 
following 4 best practices are completed as indicated:  
A. Fluid resuscitation at 30ml/kg/ Vasopressor 
administration 
B. Antibiotic administration 
C. Blood culture draws 
D. Serum Lactate level drawn  
 
 
6. The Throughput RN conveys the 4 best practices implementation 
status to the WVU Medicine attending provider.  
 
 
9. The Throughput RN completes the bed request. 
 
 
7. The Throughput RN connects the WVU Medicine attending provider 
with the outside facility provider via the MARS transfer line. 
 
 
5. The Throughput RN contacts the WVU Medicine attending provider 
via the MARS transfer phone line.  
 
 
10. The patient arrives to WVU Medicine- Ruby Memorial. 
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Appendix B 
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Appendix C 
Sepsis Screening Process Education 
 What is a WVU Medicine QSOFA screen? 
o The “QSOFA” acronym stands for: 
▪ Q-uick 
▪ S-epsis Related Organ 
▪ O-rgan  
▪ F-ailure 
▪ A-ssessment 
 
 What are the variables of a WVU Medicine QSOFA screen? 
o Altered Mental Status: GCS < 13 = 1 point 
▪ “What is the patient’s current GCS?” 
o Respiratory Rate > 22 breaths per minute = 1 point 
▪ “What is the patient’s current respiratory rate?” 
o Systolic Blood Pressure < 100 mm Hg = 1 point 
▪ “What is the patient’s current blood pressure?” 
o Serum Lactate Level > 4 mmol/ l = 1 point 
▪ “What is the patient’s serum lactate level?” 
 
 How is a WVU Medicine QSOFA screen scored? 
o Each variable has a value of 1 point 
o A WVU Medicine QSOFA score < 2 points: Negative screen and the sepsis 
expert consultation is not indicated.  
o A WVU Medicine QSOFA score > 2 points: Positive screen and the sepsis 
expert consultation is indicated. 
 
 Who is performing the WVU Medicine QSOFA screening? 
o The WVU Medicine MARS line Throughput RNs. 
 
 When is the WVU Medicine QSOFA screen taking place? 
o During the patient information collection period at the onset of an adult patient 
transfer call from an outside facility.  
 
 What is WVU Medicine QSOFA screen replacing and why? 
o What- QSOFA is replacing SIRS criteria screening. 
o Why- According to the American Medical Association previous SIRS definitions 
included: 
▪ An excessive focus on inflammation 
▪ A misleading model that follows a continuum through severe sepsis to 
shock 
▪ An inadequate specificity and sensitivity 
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▪ Multiple definitions and terminologies that lead to discrepancies in 
reported incidence and observed mortality 
 
 What are the priority interventions of the Sepsis Consultation? 
o Fluid resuscitation/ Vasopressor administration 
▪ “Has the patient received fluid resuscitation or Vasopressor 
administration?” 
o Antibiotic administration 
▪ “Has the patient received antibiotics?” 
▪ “If yes, what antibiotics have been administered?” 
o Blood culture draws 
▪ “Have blood cultures been drawn?” 
o Serum Lactate level draw  
▪ “Has a lactate level been drawn?” 
 
 When and how is the Sepsis Consultation initiated? 
o When- Following the collection of a patient transfer’s information when a WVU 
Medicine QSOFA score > 2 points exists 
o How- A MARS telephone line connection is made between the sending provider 
and the attending physician. 
 What internal providers are serving as the Sepsis Consultants? 
o All on-call attending providers and fellows for their respective WVU Medicine 
services. 
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Appendix D 
Budget Categories Personal Funds Organizational Contributions 
ADMINISTRATIVE COSTS 
  
$0 $6,760 
Administrative Justification: Education of Throughput RN staff is essential for successful 
integration of this process change. The education will be performed by 2 House supervisors 
over a period of 2 total hours at approximately $40 per hour= $160. Educational sessions will 
occur over a 1 hour period for 10 Throughput RNs at approximately $30 per hour= $300. The 
education will be supplementary to current organizational workflow and will be an 
organizational contribution. Throughout the projects implementation period of 3 months, 
there will be an additional 2 to 10 minutes per call for an average daily call volume of 50 calls 
(estimated 45 calls at 2 minutes and 5 calls at 10 minutes) conducted by Throughput RN staff 
at an approximate $30= ($1x45 calls/ $5x5 calls) $6,300. The added time spent during each 
phone call will occur as an additional step during normal workflow and will be an 
organizational contribution.  
Marketing  $0 $0 
Marketing Justification:  
EDUCATIONAL MATERIALS/ 
INCENTIVES 
$0 $50 
Educational Materials/Incentives Justification: Materials needed for successful education and 
continued support of change process through provided reference materials. Materials needed 
include paper, posters, lamination sheets, and printer ink.  
HOSPITALITY (food, room rentals, 
etc.) 
$0 $50 
Hospitality Justification: Refreshments for education sessions 
PROJECT SUPPLIES (office 
supplies, postage, printing, etc.) 
$0 $100 
Project Supplies Justification:  Current facility supplies already in place include computers, 
phones, and office space. Additional supplies needed including paper, folders, lamination 
sheets, printer ink, and 3 ring binders will be necessary as references to continually support 
the change.  
TRAVEL EXPENSES $0 $0 
Travel Expenses Justification:  
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OTHER $0 $0 
Other Justification: 
TOTALS $0 $6,960 
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Appendix E 
 
Sep-17Oct-17Nov-17Dec-17Jan-18Feb-18Mar-18Apr-18May-18Jun-18 Jul-18 Aug-18Sep-18Oct-18Nov-18Dec-18
Present Project Proposal to Committee
Project presentation to WVU Medicine Sepsis Commitee
IRB  final process
Complete EPIC build for Throughput Nurse documentation
Hold Education session with consultation MDs
Hold Education sessions with Throughput RNs
Project Implementation
Retrospective data via chart review
DNP project presentation to WVU School of nursing
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Appendix F 
Statistics 
 
Question guiding the statistical analysis: 
 
• How does the pre-intervention group differ from the post-intervention group on length of stay 
(LOS), escalation of care (EOC), and mortality?  
 
o H1: Compared to the pre-intervention group, the post-intervention group will have  
 an increase in LOS. 
o H2: Compared to the pre-intervention group, the post-intervention group will have  
 a decrease in EOC and in mortality.  
 
 
Descriptive statistics were run on the variables of LOS, EOC, and mortality in both the pre- and post-
intervention groups. Data were screened for missing data, incorrect values, and outliers. Table 1 
presents descriptive data on these variables. 
 
Table 1: Descriptive data on LOS, EOC, and mortality 
 
Group LOS EOC Mortality 
Pre-Intervention 
N = 244 
Mean: 12.77 days 
Median: 9 days 
Mode: 1 day 
EOC Yes =  46 
EOC No = 198 
Yes =  74 
No = 170 
Post-Intervention 
N = 225 
Mean: 14.84 days 
Median: 10 days 
Mode: 3 days 
EOC Yes =  34 
EOC No = 191 
Yes =  50 
No = 175 
 
 
Length of Stay (LOS) 
 
To test H1, an independent samples t-test was used to compare the pre-intervention group to the post-
intervention group on LOS. There were no significant differences in scores for the pre-intervention 
group (M = 12.77, SD = 12.33) and the post-intervention group (M = 14.84, SD = 14.54); t (441) = -1.66, p 
= .098, two tailed). The magnitude of the difference in the means (mean difference = 2.07, 95% CI: -4.53 
to 0.39) was very small (eta squared = .006). See Table 2 for output. 
 
The Levene’s test showed that the variances of the two groups are not the same (p = .018), thus the 
SPSS output of equal variances not assumed was used, and showed a non-significant difference (p = 
.098) between the two group on LOS.  
 
The descriptive statistics showed that LOS increased by 2.07 days in the post-intervention group. In 
assessing for outliers, 91% of the cases in the pre-intervention group had a LOS of 32 days or less. The 
range of the remaining 9% was from 33-70 days. For the post-intervention group, 91% of the cases had a 
LOS of 38 days or less, with the remaining 9% having a range of 39-84 days.  
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Escalation of Care (EOC) and Mortality 
 
To test H2, a one-sample chi-square analysis was used to compare the proportion of cases in the post-
intervention group with those obtained previously from a comparison sample (the pre-intervention 
group). The expected values for EOC obtained from the pre-intervention group was 19%; the expected 
value for mortality was 30%.    
 
A chi-square goodness-of-fit test indicates that there are not significant differences between the pre-
intervention and the post-intervention groups on EOC (15.5% compared to 18.9% in the pre-
intervention group) [x2 (1, n = 225) = 2.21, p = .14]; however, there are significant differences in 
mortality (22.2% compared to 30% in the pre-intervention group), x2 (1, n = 225) = 6.48, p = .01. See 
Table 3 for output.  
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